Meningitis-Related Pharmacy Recall Worsens Drug Shortage
http://www.bloomberg.com/news/2012-11-02/meningitis-related-pharmacy-recall-worsens-drug-shortage.html
The recall of hundreds of drugs by Ameridose LLC, a compounding pharmacy associated with the U.S. meningitis outbreak, may be exacerbating shortages of medicines used for surgery and heart failure, regulators said.
The Food and Drug Administration is working with other manufacturers to increase production and may consider foreign suppliers, Commissioner Margaret Hamburg said in a Web posting today. The drugs Westborough, Massachusetts-based Ameridose made were already in short supply and include local anesthesias, muscle relaxers to prevent movement during surgery and high-dose diuretics to remove fluids during congestive heart failure.
Ameridose said Oct. 31 it recalled all its products because of sterility concerns that arose after tainted drugs from New England Compounding Pharmacy Inc., a company controlled by the same people as Ameridose, were linked to meningitis infections that have killed 29 patients. Six Ameridose drugs were on the FDAs drug shortages list, according to an FDA statement yesterday. No infections have been traced to Ameridose, which suspended operations Oct. 10.
We have doubled the number of staff members who work in drug shortage prevention and response, Hamburg said. We at FDA are committed to doing everything we can, using all available tools, to prevent or mitigate drug shortages and help keep critically needed products on the market.